LOGO
LOGO

Intraday Alerts

OptimizeRx Stock Jumps 37% After Reporting Q4 Results, Outlook

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News
rttnewslogo20mar2024

Shares of OptimizeRx Corporation (OPRX) jumped over 37% on Wednesday morning after reporting results for the fourth quarter and issued an outlook for the full year 2025.

OPRX is currently trading at $5.69, up $1.55 or 37.53%, on the Nasdaq. The stock opened its trading at $4.85 after closing Tuesday at $4.14. The stock has traded between $3.78 and $14.13 in the past 52-week period.

Fourth-quarter revenues increased 14% to $32.3 million, from $28.4 million in the same period of 2023.

Net loss in the fourth quarter totaled $0.1 million or $0.00 per share compared to net loss of $4.1 million or $0.23 per share last year.

Adjusted net income in the fourth quarter was $5.5 million or $0.30 per share compared to $4.6 million or $0.26 per share last year.

Looking forward to the full year 2025, the company expects revenues to be at least $100 million with an adjusted EBITDA of at least $12 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Intelligent Investor.
Global Economics Weekly Update: April 20 – April 24, 2026

April 24, 2026 15:15 ET
Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.

Latest Updates on COVID-19